<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211229053562N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-04-18</date_registration>
      <primary_sponsor>Tarbiat Modares University</primary_sponsor>
      <public_title>A nutritional intervention study in pregnancy  based on mobile health application</public_title>
      <acronym></acronym>
      <scientific_title>Evaluating the effect of using the most appropriate existing mobile health application and an innovative mobile health application to conduct a nutritional intervention study in pregnancy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62369</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: First, the generation of random allocation sequence is done using a table of random numbers, and the two study groups are concealed as group A and group B, and then the participants will be assigned to one of the two groups according to the generated sequence.</study_design>
      <phase>2</phase>
      <hc_freetext>Condition 1: pregnancy. Condition 2: nutrition.</hc_freetext>
      <i_freetext>Intervention 1: The first Intervention group: The most suitable mobile health application available will be determined based on "the Mobile App Rating Scale" (MARS) in a preliminary study on nutritional applications available in the field of pregnancy. Mothers in the first intervention group will then receive a nutritional intervention based on the application of choice along with the necessary training on how to use the application, in addition to routine care during the Covid 19 pandemic, which has been reduced from 8 sessions to 4-5 sessions. The intervention will start from the 20th week of pregnancy. They will receive information about how to use the application, and the intervention will start from the 20th week of pregnancy. Routine follow-up and prenatal care will be provided until delivery, and maternal information including blood pressure, weight, and pregnancy complications will be recorded. In the follow-up process, the use of the nutritional intervention application will also be assessed. Intervention 2: The second intervention group:  Mothers in the second intervention group, in addition to routine prenatal care during the Covid 19 period, which has been reduced from 8 sessions to 4-5 face-to-face sessions, will receive an innovative mobile health application developed in the field of nutritional intervention by researchers in this same study. They will receive information about how to use the application and the intervention will start from the 20th week of pregnancy. Routine follow-up and prenatal care will be provided until delivery, and maternal information including blood pressure, weight, and pregnancy complications will be recorded. In the follow-up process, the use of the nutritional intervention application will also be assessed. Intervention 3: Control group: Mothers in the control group will receive only routine pregnancy care, which according to the clinical guideline of Covid 19 disease in pregnancy, in low-risk pregnancies, the number of face-to-face care is 4-5 times according to the conditions of the residence area and absentee care is 4 times. Routine prenatal care and follow-up will be performed until delivery, and prenatal care information including blood pressure, weight, and pregnancy complications will be recorded.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
At the end of the study, the final report will be provided in 2 forms: 
- A theses for obtaining an MSc degree in Tarbiat Modares University
- The final report of the approved research by the Iran National Scientific Foundation
 In both reports, details of the study protocol, statistical analysis map, and informed consent form will be mentioned.
In addition, after the publication of the final report and also the articles extracted from the data of this project, at the request of researchers and scientific centers related to the research topic, data file, study protocol, statistical analysis map, informed consent form, and codes used in the analysis will be provided for them.

When:
After the end of the study, and publication of the mentioned reports

To whom:
Researchers and scientific centers related to the research topic

Conditions:
In case of sending a written request via e-mail, and in order to use the results of the study in executive and research fields in order to promote pregnancy health

Where to obtain:
Person in charge of the scientific research, Lida Moghaddam-Banaem

How to obtain:
- Sending an email to the person in charge of the scientific research
- Sending the mentioned request to the members of the research team
- Assessment of the request by the research team
- Sending the requested items to the applicant person or center, if approved by the research team, by the person in charge of the scientific research

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Lida Moghaddam-Banaem</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Al-e-Ahmad Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713116</zip>
        <telephone>+98 21 8288 3857</telephone>
        <email>moghaddamb@modares.ac.ir</email>
        <affiliation>Tarbiat Modares University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Lida Moghaddam-Banaem</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Reproductive Health and Midwifery, Faculty of Medical Sciences&lt; Tarbiat Modares University, Al-e-Ahmad Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713116</zip>
        <telephone>+98 21 8288 3857</telephone>
        <email>moghaddamb@modares.ac.ir</email>
        <affiliation>Tarbiat Modares University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Iranian citizenship
Resident of Tehran province
18 -45 years old
Singleton pregnancy
Having a smartphone
Ability to read and speak Persian to understand the content of the application
Gestational age less than 20 weeks</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Chronic systemic diseases such as diabetes, hypertension, respiratory diseases, kidney diseases, and polycystic ovary syndrome, ...
Eating disorders
Use of any medication except for routine pregnancy supplements
Any movement disorders</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first Intervention group: The most suitable mobile health application available will be determined based on "the Mobile App Rating Scale" (MARS) in a preliminary study on nutritional applications available in the field of pregnancy. Mothers in the first intervention group will then receive a nutritional intervention based on the application of choice along with the necessary training on how to use the application, in addition to routine care during the Covid 19 pandemic, which has been reduced from 8 sessions to 4-5 sessions. The intervention will start from the 20th week of pregnancy. They will receive information about how to use the application, and the intervention will start from the 20th week of pregnancy. Routine follow-up and prenatal care will be provided until delivery, and maternal information including blood pressure, weight, and pregnancy complications will be recorded. In the follow-up process, the use of the nutritional intervention application will also be assessed.</i_keyword>
      <i_keyword>The second intervention group:  Mothers in the second intervention group, in addition to routine prenatal care during the Covid 19 period, which has been reduced from 8 sessions to 4-5 face-to-face sessions, will receive an innovative mobile health application developed in the field of nutritional intervention by researchers in this same study. They will receive information about how to use the application and the intervention will start from the 20th week of pregnancy. Routine follow-up and prenatal care will be provided until delivery, and maternal information including blood pressure, weight, and pregnancy complications will be recorded. In the follow-up process, the use of the nutritional intervention application will also be assessed.</i_keyword>
      <i_keyword>Control group: Mothers in the control group will receive only routine pregnancy care, which according to the clinical guideline of Covid 19 disease in pregnancy, in low-risk pregnancies, the number of face-to-face care is 4-5 times according to the conditions of the residence area and absentee care is 4 times. Routine prenatal care and follow-up will be performed until delivery, and prenatal care information including blood pressure, weight, and pregnancy complications will be recorded.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pregnancy weight gain. Timepoint: Beginning of the study (before the intervention), 31 to 34 weeks of gestation, time of delivery. Method of measurement: Will be extracted from the mother's prenatal care record.</prim_outcome>
      <prim_outcome>Anthropometric indices of the newborn including weight, height, and head circumference. Timepoint: At birth. Method of measurement: Based on the measurements recorded on the newborn's birth card.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Gestational age at birth. Timepoint: Time of delivery. Method of measurement: Will be extracted from the mother's prenatal care and delivery records.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Iran National Science Foundation</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tarbiat Modares University</source_name>
      <source_name>Iran National Science Foundation</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-12-25</approval_date>
        <contact_name>Ethics committee of Tarbiat Modares University</contact_name>
        <contact_address>Ai-e-Ahmad Highway, Tarbiat Modares University Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
